Literature DB >> 20164765

Temporal trends in the burden of chronic kidney disease in the United States.

Robert N Foley1.   

Abstract

PURPOSE OF REVIEW: The public health importance of chronic kidney disease (CKD) has only recently come to be appreciated and careful examination of temporal trends is warranted. The purpose of the present review was to examine existing research on temporal trends for CKD and treated end-stage renal disease (ESRD) in the United States. RECENT
FINDINGS: When the broadly representative National Health and Nutrition Examination Survey (NHANES) datasets were compared in 1988-1994 and 1999-2002, a pronounced increase in the prevalence of abnormally low glomerular filtration rate was observed when serum creatinine was used to estimate glomerular filtration rate. In contrast, glomerular filtration rate findings were almost identical when cystatin C levels were examined. Thus, although the community-wide burden of CKD is already high, uncertainty exists as to the growth rate of this problem. For treated ESRD a dramatic increase in incidence rate occurred in the 1980s and 1990s. Changing burdens of standard risk factors for CKD do not readily explain increased rates of treated ESRD, suggesting that selection criteria for dialysis and transplant programs may underlie these secular trends. If the hypothesis that nonbiological factors are major determinants of rates of treated ESRD is valid, the latter may be a poor surrogate for true ESRD and for understanding its causes and rates of progression.
SUMMARY: Given its prevalence and prognostic implications, it makes intuitive sense to monitor the burden of CKD over time; the validity of the tools used to generate an answer, however, is at least as important as the direction of the answer.

Entities:  

Mesh:

Year:  2010        PMID: 20164765     DOI: 10.1097/MNH.0b013e328337bba7

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  8 in total

1.  Trends in the levels of urine and serum creatinine: data from NHANES 2001-2014.

Authors:  Ram B Jain
Journal:  Environ Sci Pollut Res Int       Date:  2017-03-06       Impact factor: 4.223

2.  Mitochondrial Damage and Activation of the STING Pathway Lead to Renal Inflammation and Fibrosis.

Authors:  Ki Wung Chung; Poonam Dhillon; Shizheng Huang; Xin Sheng; Rojesh Shrestha; Chengxiang Qiu; Brett A Kaufman; Jihwan Park; Liming Pei; Joseph Baur; Matthew Palmer; Katalin Susztak
Journal:  Cell Metab       Date:  2019-08-29       Impact factor: 27.287

3.  Variability in CKD stage in outpatients followed in two large renal clinics.

Authors:  Tabo Sikaneta; Mohamed Abdolell; Hulya Taskapan; Janet Roscoe; Jason Fung; Gordon Nagai; Robert H Ting; Paul Ng; George Wu; Dimitrios Oreopoulos; Paul Y Tam
Journal:  Int Urol Nephrol       Date:  2011-03-20       Impact factor: 2.370

4.  Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: prevalence of and risk factors for diabetes mellitus in CKD in the Kidney Early Evaluation Program (KEEP).

Authors:  Samy I McFarlane; Peter A McCullough; James R Sowers; Kyaw Soe; Shu-Cheng Chen; Suying Li; Joseph A Vassalotti; Lesley A Stevens; Moro O Salifu; Manjula Kurella Tamura; Andrew S Bomback; Keith C Norris; Allan J Collins; George L Bakris; Adam T Whaley-Connell
Journal:  Am J Kidney Dis       Date:  2011-03       Impact factor: 8.860

5.  Estimated Glomerular Filtration Rate, Activation of Cardiac Biomarkers and Long-Term Cardiovascular Outcomes: A Population-Based Cohort.

Authors:  Shravya Vinnakota; Christopher G Scott; Richard J Rodeheffer; Horng H Chen
Journal:  Mayo Clin Proc       Date:  2019-10-23       Impact factor: 7.616

6.  Association of reduced renal function with hepatitis B virus infection and elevated alanine aminotransferase.

Authors:  Jianfang Cai; Xiaohong Fan; Lijun Mou; Bixia Gao; Xuejiao Liu; Jinhong Li; Lili Liu; Haiyun Wang; Zengyu Guo; Xiaoqing Liu; Hang Li; Xuemei Li; Xuewang Li
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-02       Impact factor: 8.237

7.  Peritoneal dialysis in diabetics: there is room for more.

Authors:  P Cotovio; A Rocha; A Rodrigues
Journal:  Int J Nephrol       Date:  2011-10-16

8.  Jagged1/Notch2 controls kidney fibrosis via Tfam-mediated metabolic reprogramming.

Authors:  Shizheng Huang; Jihwan Park; Chengxiang Qiu; Ki Wung Chung; Szu-Yuan Li; Yasemin Sirin; Seung Hyeok Han; Verdon Taylor; Ursula Zimber-Strobl; Katalin Susztak
Journal:  PLoS Biol       Date:  2018-09-18       Impact factor: 8.029

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.